BionX™ Medical Technologies, Bedford, Massachusetts, has completed a Series E funding round. The most recent funding was led by ZGC Shiner Investment, a Beijing, China-based investor, along with the existing investors. BionX has raised $17 million so far in this round, proceeds of which will be used for commercial expansion in the United States and internationally, as well as product development, according to a BionX press release.
BionX said it plans to complete a total raise of $25 million in Series E financing by the end of the first quarter of 2016.
